The Dark Side of Gender Ideology, BDSM, and Detransition - Victoria (#7)
3 April 2025
With Victoria
UK
Victoria's account of a decade living as transgender — including DIY hormone use and its documented health consequences — illustrates systemic gaps in formal care. The episode examines NHS failures for detransitioners, the clinical evidence on autism and gender-clinic referrals, and the safeguarding risks that arise when gender-identity communities overlap with fetish subcultures. Her testimony adds a first-person dimension to concerns that the Cass Review and emerging clinical literature have only recently begun to address.
Victoria spent roughly a decade identifying as transgender before detransitioning — a journey that included sourcing and using hormones outside formal medical supervision. The clinical risks of unsupervised cross-sex hormone use are well documented: cardiovascular complications, disrupted endocrine function, and long-term sequelae that remain poorly characterised in the literature. Her account makes visible what happens when formal healthcare pathways are inaccessible or subject to years-long waiting lists, and individuals reach for alternatives that carry no monitoring, no structured informed-consent process, and no safety net. A substantial part of the conversation concerns the structural overlap Victoria observed between gender-identity communities and BDSM or fetish subcultures. She describes recruitment dynamics, the normalisation of escalating practices, and failures of consent within spaces that styled themselves as progressive and safe. This sits alongside a growing body of research on online community effects in adolescent identity formation, and raises questions about which populations are most at risk of harm when these subcultures intersect. Victoria speaks at length about the particular vulnerability of autistic women in these environments — a concern that now appears prominently in clinical literature. The NHS Cass Review, commissioned to examine England's gender medicine pathway for young people, identified elevated rates of autism and other neurodevelopmental conditions among those referred to gender clinics, and recommended far more thorough assessment of co-occurring conditions before any clinical pathway is initiated. The rationale is well grounded: autistic individuals may be disproportionately susceptible to social influence and may interpret distress through frameworks offered by peer communities rather than from longstanding internal experience. Victoria introduces the term empathy hijacking to describe a dynamic she witnessed directly: predatory individuals adopting the language and position of victims to gain trust within communities organised around shared vulnerability. The mechanism has close parallels in the psychological literature on coercive control and grooming. It also points to a safeguarding failure in communities that are culturally resistant to external scrutiny and that tend to frame any challenge to member behaviour as political persecution rather than legitimate concern. The episode ends on the near-total absence of structured clinical support for detransitioners. Victoria describes a medical vacuum after she ceased cross-sex hormones — a period when both endocrine readjustment and psychological care are clinically important. The Cass Review and subsequent NHS England policy documents have acknowledged detransitioners as an under-served group, yet systematic care pathways remain largely absent across the UK and in European health systems more broadly. The gap between policy acknowledgement and actual clinical provision is, by her account, very wide. First-person testimony of this kind is difficult to capture in randomised trials, yet clinicians and policymakers reviewing gender medicine outcomes are increasingly recognising its evidential value. Victoria's trajectory — from early identity confusion, through DIY hormone use and community exploitation, to detransition without adequate clinical support — represents one detailed case study in an urgent and still-unresolved debate about safeguarding standards, informed consent, and the duty of care owed to gender-questioning individuals within European healthcare systems.
